Cannabinoids: clearing the smoke on pain, inflammation and neurodegeneration

Br J Pharmacol. 2014 Mar;171(6):1341-4. doi: 10.1111/bph.12642.

Abstract

This article is part of a themed section on Cannabinoids 2013. To view the other articles in this section, see Fagan and Campbell (2014) DOI: 10.1111/bph.12492, Ignatowska-Jankowska et al. (2014) DOI: 10.1111/bph.12298, Ligresti et al. (2014) DOI: 10.1111/bph.12410, Lopez-Rodriguez et al. (2014) DOI: 10.1111/bph.12519, Murataeva et al. (2014) DOI: 10.1111/bph.12411, Okine et al. (2014) DOI: 10.1111/bph.12540, Rodríguez-Cueto et al. (2014) DOI: 10.1111/bph.12283, Stanley and O'Sullivan (2014) DOI: 10.1111/bph.12560, Toguri et al. (2014) DOI: 10.1111/bph.12545, Wu et al. (2014) DOI: 10.1111/bph.12500. Linked articles are: Avraham et al. (2014) DOI: 10.1111/bph.12478, Machado et al. (2014) DOI: 10.1111/bph.12488, Ward et al. (2014) DOI: 10.1111/bph.12439.

Publication types

  • Editorial

MeSH terms

  • Animals
  • Cannabinoids / therapeutic use*
  • Humans
  • Inflammation / drug therapy*
  • Mice, Transgenic
  • Neurodegenerative Diseases / drug therapy*
  • Pain / drug therapy*

Substances

  • Cannabinoids